Viewing StudyNCT03294694



Ignite Creation Date: 2024-05-06 @ 10:34 AM
Last Modification Date: 2024-10-26 @ 12:32 PM
Study NCT ID: NCT03294694
Status: TERMINATED
Last Update Posted: 2022-03-31
First Post: 2017-09-19

Brief Title: Ribociclib PDR001 in Breast Cancer and Ovarian Cancer
Sponsor:
Organization: Dana-Farber Cancer Institute